59 results
8-K
EX-99.2
GLYC
GlycoMimetics Inc
6 May 24
Results of Operations and Financial Condition
4:01pm
follow-up for the substantial majority of remaining patients that received stem cell transplants After 2 years post-transplant, AML relapse becomes
PRE 14A
GLYC
GlycoMimetics Inc
22 Mar 24
Preliminary proxy
5:00pm
year ending December 31, 2024
“FOR” votes from a majority of the shares present online or represented by proxy at the Annual Meeting and entitled to vote …
“FOR” votes from a majority of the shares present online or represented by proxy at the Annual Meeting and entitled to vote on the matter is required
8-K
EX-99.1
GLYC
GlycoMimetics Inc
1 Mar 24
Regulation FD Disclosure
9:16am
follow-up for the substantial majority of remaining patients that received stem cell transplants After 2 years post-transplant, AML relapse becomes
8-K
EX-10.1
lft5r
20 May 22
Departure of Directors or Certain Officers
1:09pm
8-K
q8ejbqcdwry7qk9gs
28 Feb 20
Glycomimetics Reports Highlights and Financial Results for Fourth Quarter and Year-end 2019
11:00am